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Nitric oxide is an important mediator of inflammatory responses in the lung and a key regulator
of pulmonary vascular and bronchomotor tone. We have shown that the inducible nitric oxide
synthase (iNOS) isoform is continuously expressed in human airway epithelium at mRNA and
protein/activity levels in vivo. However, removal of epithelial cells from the in vivo airway
environment resulted in rapid loss of iNOS expression, which suggested that expression is
dependent upon conditions and/or factors present in the airway. To investigate the mechanisms
responsible for maintenance of expression in vivo, we evaluated regulation of iNOS expression
in primary human airway epithelial cells. Interferon-y (IFNI' was sufficient for induction of iNOS
in primary human airway epithelial cells (HAEC) in vitro, and interleukin-4 (IL-4) potentiated the
expression through stabilization of iNOS mRNA. The IFN-y/IL-4-induced iNOS expression in
HAEC was delayed in onset and prolonged with expression up to 1 week. Furthermore, transfer
of overlying culture media [conditioned media (CM)] to other HAEC led to iNOS induction.
Interestingly, IFN-y/IL-4 induction of iNOS was dependent on new protein synthesis, whereas
CM induction of iNOS was not. IFN-,y and IL-4 activated signal transducers and activators of
transcription (STAT1 and STAT6) in HAEC, but CM transfer to HAEC produced even higher
levels of STAT1 activation than achieved by direct addition of cytokines. Thus, IFN-y/IL-4, which
occurs in human lung lining fluid, led to iNOS expression in human airway epithelium through
production of soluble mediators and stabilization of mRNA. Environ Health Perspect
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Introduction
Nitric oxide ('NO) has many proposed
biological functions in the lung, including
modifying airway tone, regulating pul-
monary vascular tone, stimulating mucin
secretion, modulating mucociliary clearance
through effects on ciliary beat frequency,
and immune surveillance including tumori-
cidal and bactericidal effects (1). Three
types of nitric oxide synthases (NOS; EC
1.14.13.39), the enzymes responsible for
endogenous 'NO production, have been
described in human cells. Two are consti-
tutive isoforms (neuronal NOS and
endothelial NOS) with activities regulated
by intracellular calcium/calmodulin pro-
ducing picomolar levels ofNO (2). A third
form of NOS (iNOS), which produces
nanomolar levels of NO, is induced by
microbes, microbial products, or cytokines
and is independent ofcalcium for activity
(2,3). Previously, immunostaining of
the lung indicated that iNOS was the
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prominent isoform expressed in human
airwayepithelium in vivo (4,5).
However, overproduction of NO by
iNOS has been proposed as one mecha-
nism of amplifying and/or perpetuating
lung inflammation and injury. In this con-
text, endogenous overproduction of NO
has been implicated in the pathogenesis
of asbestos-related carcinogenesis (6),
inflammatory disorders in the lung, such
as asthma, bronchiectasis, and chronic
obstructive pulmonary diseases (7,8), and
in sepsis-related acute lung injury (8). The
mechanism ofinjury by 'NO is likely medi-
ated through its reaction with superoxide to
form peroxynitrite, a strong oxidant that
can react with biologic molecules resulting
in major pathologic consequences (8). For
example, 'NO in association with super-
oxide plays a pathogenic role in the lung
injury from influenza viral pneumonia (9).
In addition, 'NO and oxidants contribute to
the epithelial injury and shedding described
in the asthmatic airway (7). Similarly, the
human immunodeficiency virus structural
envelope glycoprotein gpl20 induces iNOS
expression and increased formation ofan
'NO radical, which leads to cytotoxic effects
(10). The 'NO radical is involved in the
hydroxylation ofdeoxyguanosine in DNA,
which leads to 8-hydroxydeoxyguanosine, a
potentially carcinogenic DNA lesion (6).
Thus the carcinogenicity ofasbestos, a natu-
rally occurring mineral fiber that induces
iNOS and oxidant formation in lung
cells, may be due in part to the formation of
*NO radicals (6).
With the knowledge that 'NO plays an
important role in both normal lung
processes and in the pathogenesis oflung
diseases, we have characterized the expres-
sion of iNOS in human airway epithelial
cells (HAEC) in vivoand in vitro.
iNOS Expression in Human
Airway Epithelium in Vivo
Initially, we used a reverse transcription-
polymerase chain reaction (PCR) cloning
strategy to clone human epithelial NOS.
HAEC were obtained through broncho-
scopy with a flexible fiberoptic broncho-
scope from normal nonsmoking volunteers
with no history oflung disease and on no
medications. A contiguous cDNA sequence
of3966 bp compiled from sequences ofthe
five overlapping PCR products demon-
strated a 3459 bp open reading frame
encoding a peptide of 1153 amino acids
(11). Comparison of this respiratory
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epithelial cDNAwith human iNOS cDNA
sequences from hepatocyte, two types of
chondrocytes, and a colorectal adenocarci-
noma cell line (12-15) showed that except
for two sequence discrepancies resulting in
one amino acid change, our respiratory
epithelial NOS was in agreement with
the known iNOS sequences (Genbank
accession U20141).
To quantitate expression of iNOS in
human airway epithelium, we performed
Northern blot analyses oftotal RNA from
HAEC freshly obtained by bronchoscopic
brushing of normal nonsmoking volun-
teers. Abundant levels ofiNOS gene tran-
script were demonstrated as a prominent
signal at 4.5 kb in all HAEC samples
using a 32P-labeled iNOS cDNA probe
(pCCF21) (Figure IA) (11). In contrast,
constitutive endothelial type NOS was not
detected in HAEC byNorthern blot analy-
sis using a full-length human endothelial
NOS cDNA probe (16). Northern blot
analysis of normal human airway epithe-
lium from bronchi obtained at surgical
lung resections also demonstrated abun-
dant continuous expression of iNOS
(Figure IA). In contrast to the high levels
ofiNOS seen in the airway epithelial cells,
Northern blot analysis of total RNA
immediately extracted from human alveo-
lar macrophages obtained by bronchoalve-
olar lavage (BAL) ofnormal nonsmoking
volunteers or peripheral human lung tis-
sues demonstrated no iNOS expression
(Figure IA) (11). Thus, airway epithelium
of normal nonsmoking individuals
uniquely expressed the iNOS mRNA at
high levels under basal unstimulated
conditions in vivo.
To determine whether the abundant
iNOS mRNA expression was paralleled by
similarly abundant iNOS enzyme content
in airway epithelial cells, we evaluated
iNOS protein expression and function.
Western blot analyses using a monoclonal
anti-iNOS antibody demonstrated a pro-
tein band in airway epithelial cell lysates
from normal volunteers that was similar
in size to iNOS induced in the mouse
macrophage cell line (RAW264.7) with
interferon-y (IFN-y) and lipopoly-
saccharide (LPS) (Figure 1B) (11). In addi-
tion, NOS enzyme activity was quantitated
in the HAEC cell lysates by measuring the
conversion of 14C-L-arginine to 14C-L-
citrulline in the presence ofsaturating con-
centrations ofthe enzyme's cofactors (11).
Positive control of mouse macrophage
lysate from RAW264.7 stimulated with
IFN-,y and LPS converted L-arginine to
L-citrulline at 6 ± 1 nmol/min/mg cell
lysate, which is similar to previously
reported levels for these cells (2). In the
lysate from the freshly obtained unstimu-
lated HAEC, L-arginine was converted to
L-citrulline at 1.1 ± 0.3 nmol/min/mg cell
lysate (11). These levels ofnanomolar con-
version ofsubstrate are in agreement with
the known activity of iNOS and are an
order ofmagnitude above what would be
expected to be produced by the traditional
constitutive isoforms ofNOS (2). These
results confirm that iNOS is abundantly
and continuously expressed at the
mRNA and protein levels in human airway
epithelium in vivo.
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Figure 1. Expression of iNOS in airway epithelial cells
in vivo. (A) Northern blot analysis of total RNA from
various human lung cells was performed using
32P-labeled iNOS cDNA. Freshly obtained HAEC from
bronchial brushing of a normal volunteer (lane 1, 1 pg)
and surgically resected human bronchus (lane 2, 1 pg
total RNA); peripheral human lung tissue (lane 3, 5pg
total RNA); human alveolar macrophages from a nor-
mal volunteer (lane 4, 5 pg total RNA). Human
32P-labeled y-actin cDNA hybridization is shown as
control (lanes 5-8). (B) Western blot analysis of iNOS.
Positive control of mouse macrophage cell line
(RAW264.7) stimulated with IFN-y and LPS (lane 1, 6
pg protein). A protein ofthe expected size of iNOS (131
kDa) was detected in all the HAEC lysates (lanes 2-5,
50 pg protein/lane). Data from Guo etal. (11).
Loss of iNOS Expression
in Airway Epithelial Cells
ex Vivo
Although iNOS expression was present at
high levels in vivo, expression was lost
ex vivo. Airway epithelial cells obtained by
bronchoscopic brushing of normal non-
smoking volunteers were divided into three
aliquots for culture in serum-free Lechner
and LaVeck media (LHC8, Biofluids,
Rockville, MD) for 0, 8, and 24 hr, and
RNA was extracted to determine iNOS
expression by Northern blot analysis (11).
The iNOS expression decreased in culture
in a time-dependent fashion in agreement
with the previously reported mRNA half-
life of4 hr (17); by 24 hr ofculture iNOS
mRNA was not detectable by Northern
blot analysis (Figure 2) (11).
iNOS Gene Induction in Vitro
Previous in vitro studies have demon-
strated that, similar to other human and
murine cell lines, iNOS is induced in
human lung epithelial cell lines and pri-
mary HAEC by cytokine combinations
including IFN-y, interleukin (IL)-10 (IL-
1P), and tumor necrosis factor a (TNF-a)
(18,19). Thus, using primary HAEC in
culture, we investigated the mechanisms
regulating iNOS expression in human res-
piratory epithelium. As previously shown,
iNOS gene induction in HAEC was
demonstrated in response to cytokine
combinations including IFN-y, IL-1,3, and
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Figure 2. Loss of iNOS expression in HAEC placed ex
vivo. RNA extracted from HAEC cultured for 0, 8, and
24 hr was analyzed by Northern blot analysis for iNOS
expression (1 pg total RNA/lane) (inset). The graph
demonstrates decreases in iNOS mRNA over time as
percentage of y-actin mRNA (n=4, mean±SE). Data
from Guo etal. (11).
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TNF-a. Although IFN-y alone induced
iNOS mRNA expression in HAEC, the
levels ofiNOS mRNA were less than lev-
els induced by IFN-y and IL-4 (Figure 3)
(20). However, IL-4 alone did not induce
iNOS expression, indicating potentiation
ofIFN-yinduction ofiNOS by IL-4 (20).
The time course of iNOS induction in
HAEC was delayed and prolonged after
IFN-'y and IL-4 stimulation (Figure 4A)
(20). This is in contrast to other primary
cultured cells such as hepatocytes, in
which iNOS induction occurs in response
to cytokines as early as 2 hr, with peak lev-
els at 4 to 6 hr (21). This combination of
cytokines may be especially relevant to in
vivo iNOS expression, as human lungs
contained IFN-y and IL-4 in epithelial
lining fluid in vivo at levels that would
lead to iNOS induction (IL-4 = 9 ± 5
pg/ml BAL fluid and IFN-y= 33 ± 11
pg/ml BAL fluid; mean ± SE, n= 13) (20).
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IL-4 Prolongs iNOS mRNA
Half-Life in Human Airway
Epithelial Cells
IL-4 inhibits iNOS expression in some
studies and induces 'NO production in
other studies (22,23). The potentiation of
mRNA levels by IL-4 in some instances,
such as vascular cell adhesion molecule 1,
has been attributed to increases in the half-
life ofthe mRNA (24). Furthermore, stabi-
lization ofiNOS mRNA is one mechanism
through which endotoxin potentiates IFN-
y-induced iNOS expression in the mouse
macrophage-like cell line (25).
To investigate the potentiation ofIFN-y
induction ofiNOS by IL-4, the half-life of
iNOS mRNA was determined in HAEC
stimulated with IFN-y, or IFN-y and IL-4,
and compared to lung adenocarcinoma cell
line A549 stimulated with IFN-y, IL-1f,
and TNF-a. The half-life ofiNOS mRNA
in IFN-y/IL-4-stimulated HAEC (6.6 ± 0.5
hr) was longer than that in IFN-y-stimulated
HAEC (3.7 ±0.6 hr) or IFN-y/IL-1P/TNF-
a-stimulated A549 cells (3.8 ± 0.5 hr) (20).
So although the half-life ofiNOS mRNA in
IFN-y-stimulated HAEC was comparable to
previously determined iNOS mRNA half-
life (17), the addition ofIL-4 prolonged the
half-life ofiNOS mRNA in HAEC. Thus,
iNOS mRNA levels are regulated in HAEC
partially at the level ofmRNAstability.
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Figure 3. iNOS gene induction in respiratory epithelial
cells in vitro. Primary HAEC (lanes 1-3), transformed
human bronchial epithelial cell line (BEAS2B, lanes 4,
5), and lung adenocarcinoma epithelial cell line (A549,
lanes 6-9) were cultured in the presence of various
combinations of cytokines as indicated for 8 and 24 hr.
Northern blot analyses of RNA (5 pg total RNA/lane)
were performed using 32P-labeled human iNOS cDNA,
and as a control, 18S cDNA. Relative units of iNOS
mRNA/18S are summarized in the graph, with mean
values and SD demonstrated. Data from Guo etal. (20).
Soluble Mediators Maintain
iNOS Expression in HAEC
in Response to a Single
Stimulation Event
Our results showed that iNOS mRNA
levels in HAEC were maximal at 24 hr and
present up to 7 days after asingle initiating
stimulation with IFN-y and IL-4 (Figure
4A). Interestingly, persistence of iNOS
expression in HAEC in culture was depen-
dent on maintaining the overlying tissue
culture media. HAEC were cultured in
LHC8 on plates precoated with coating
media containing 29 pg/ml collagen (vitro-
gen from Collagen Corp, Palo Alto, CA),
10 pg/ml bovine serum albumin (Biofluids,
Rockville, MD), and 10 pg/ml fibronectin
(Calbiochem, La Jolla, CA) (20). After
stimulation with IFN-,y and IL-4 and cul-
ture for 6 days in this media (20), the cell-
free overlying tissue culture media is
referred to as the conditioned media (CM).
Transfer ofthe CM to other HAEC in cul-
ture induced iNOS gene expression,
whereas transfer ofCM to A549 or trans-
formed bronchial epithelial cells (BEAS2B)
did not lead to iNOS induction (Figure
4B) (20). Despite minimal levels ofIFN-,y
remaining in CM, CM transfer to other
HAEC resulted in levels ofiNOS induction
similar to those found with the addition of
fresh IFN-,yand IL-4 (Figure 4B) (20).
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Figure 4. (A) Prolonged time course of iNOS mRNA expression in HAEC induced by IFN-y and IL-4. HAEC were
cultured in the presence ofIFN-y(100 U/mI) and IL-4(10 ng/ml) for8 hrto 6days. Relative units of iNOS mRNA/18S
of all times evaluated are summarized in the graph, with mean values connected by the dashed line and SD
demonstrated. Inset: representative Northern blotanalysis (5 pg oftotal RNA/lane). (B) Soluble mediator(s) lead to
iNOS expression in HAEC. HAEC were cultured in IFN-y(100 U/mI) and IL-4(10 ng/ml) for 7 days, (lane 1) or 6 days
following which overlying tissue culture media [conditioned media (CM)] was removed and the HAEC cultured for
an additional 24 hr in fresh media (FM) (lane 2). The 6-day CM was transferred to HAEC(lane 3), A549(lane 4), or
BEAS2B (lane 5), and cultured for 24 hr. Total RNA from cells were extracted and levels of iNOS mRNA, and as a
control 18S RNA, were assessed by Northern blotanalysis(5 pg total RNA/lane) Data from Guo et al. (20).
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Furthermore, wash-off experiments
confirmed that soluble mediators in the CM
were responsible for maintenance ofiNOS
expression. Following 1- or 24-hr incuba-
tion of HAEC with IFN-,y and IL-4, the
cells were vigorously washed with HEPES-
buffered saline and cultured in fresh media
(FM) without cytokines for 47 or 24 hr,
respectively. Northern blot analysis showed
that iNOS expression in the HAEC exposed
to IFN-,yand IL-4 for 1 hr was 90 ± 10% of
the iNOS mRNA levels in HAEC cultured
with IFN-,y and IL-4 continuously for 2
days (Figure 5) (20). However, the levels of
iNOS mRNA in the HAEC were markedly
decreased to 15 ±5% ofthe positive control
ifmedia was removed after 24-hr culture
(Figure 5) (20). These results indicated that
IFN-y and IL-4-induced iNOS mRNA
expression in HAEC was dependent upon
soluble mediator(s). The majority of the
mediator(s)' synthesis and/or secretion
appeared to occur 1 to 24 hr after IFN-y
and IL-4 stimulation.
Protein Synthesis
Dependence of iNOS
mRNA Induction in HAEC
To determine ifthe mediators leading to
transferable and prolonged iNOS expression
in HAEC were dependent on new protein
18S
1 2 3
Figure 5. Dependence on early synthesis of
mediator(s) for IFN-y/lL-4-induced iNOS expression in
HAEC. HAEC were cultured with IFN-,y (100 U/mi) and
IL-4 (10 nglml) for 1 hr (lane 1) or 24 hr (lane 2), then
media containing IFN-y/1L-4 were removed and cells
were washed and cultured in FM without cytokines for
47 and 24 hr, respectively. HAEC were also cultured in
the presejice of IFN-,y/IL-4 for 48 hr (lane 3). Northern
blot analysis of total RNA from HAEC (5 pg/lane) was
performed with 32p-labeled iNOS cDNA and 18S cDNA.
Data from Guo et al. (20).
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oheximide, iNOS complex class 11(31,32). The mechanisms
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nhibitor (Figure 6) understood (31,32). Induction ofiNOS in
duction of iNOS HAEC by IFN-y displays characteristics of
the CM was not a secondary response gene, such as delayed
sence of cyclohex- time to expression, enhancement ofinduc-
NA levels in HLAEC tion by additional cytokines (TNF-ac, IL-
in the presence of 1P, IL-4), and requirement ofnew protein
0% of iNOS levels synthesis. In contrast, the induction of
d with CM alone iNOS in HAEC by CM did not require
new protein synthesis, indicating that the
Mobility
process ofiNOS induction by CM is not a
secondary effect and is different than the
IL-4/IFN-y-stimulated iNOS induction.
fied as a key factor Possible mechanisms considered for the
ranscription in vari- persistent iNOS mRNA expression in
Janus OAK) signal HAEC included continued signaling by
(26). Further, the cytokines from cell surface receptors or
ne, human IFN reg- inhibition of intracellular signal decay,
-1), has also been which would lead to sustained activation of
or iNOS activation STATI (26,32). Either of these processes
s (27). Signal trans- could lead to continuing iNOS gene
through tyrosine expression. To investigate the involvement
,TAT1 (26). IL-4 of the JAK-STAT pathway in our system,
east in part through electrophoretic mobility shift assays
). Binding elements (EMSA) with whole cell extract from
;e and human iNOS HAEC stimulated with IFN-,y (100 U/ml)
escribed, and in the and IL-4 (10 ng/ml) for 15 min, 8 hr, and
DS gene, transcrip- 6 days were performed using the IFN-y
Pendent upon these activation site oligonucleotide (5'-tcga
eral, IFN-y binding GCCTGATTTCCCCGAAATGACGGC-
rs initiates signals 3') corresponding to the IRF-1 promoter
the nucleus and lead from base pairs -130 to -106 sequence rel-
rn of a number of ative to transcription start point (IRF-1
primary response GAS) (26). The results indicated a single
of de novo protein major binding complex was induced using
the IRF-1 GAS (Figure 7). This binding
complex was confirmed to contain STAT1
by supershifting with antihuman STATI
antibodies (Figure 7). In contrast, no
STAT1-containing complex was detected
in nonstimulated HAEC in culture. The
2 3 4 5 STATI complex was detected at 6 days in
+ culture after IFN-y and IL-4 stimulation,
+ although the level of activation was less
+ than that observed at 15 min or 8 hr after
+ + + stimulation (Figure 7).
+ + Although activation ofSTATI byIFN-y
in HAEC has been demonstrated in the
,-dependent mediator(s) past (31), activation ofSTAT6 by IL-4 in
in HAEC. iNOS mRNA these cells was previously unknown. Using 100 U/mi) and IL-4(lane 1,
10 pg/mI cycloheximide a GAS element that preferentially binds
Iced iNOS mRNA (lane 4) STAT6 [IL4 GAS (5'-GATTTTCC
cloheximide (lane 5). CAGAAAAGGAAC-3') corresponding to
iffect on iNOS expression the human high-affinity IgG receptor gene
uoetal.(20). promoter from -33 to -14 bp] (28),
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Figure 7. Activation of signal transducers and activators of transcription in HAEC. EMSA of DNA-protein
complexes (5 pg protein/lane) were resolved on nondenaturing 6% polyacrylamide gels, followed by autoradio-
graphy. EMSA of whole cell extracts from nonstimulated HAEC had no STAT activation (not shown). EMSA of
whole cell extracts from HAEC incubated with IFN-,yand IL-4 for 8 hr (lanes 1, 2) and 6 days (lanes 3-5)were per-
formed using 32P-labeled IRF-1GAS element, or from HAEC incubated with CM for 15 min (lanes 6-13) using
32P-labeled IRF-1GAS element (lanes 6-9) or [l-4 GAS element (lanes 10-13). Unlabeled oligonucleotide IRF-1GAS
or IL-4 GAS at 100 times molar excess of32P-labeled, and rabbit anti-STAT1 or STAT6 polyclonal antibodies (pAb,
2 pg) were added to the binding reactions as indicated to verify STAT1 or STAT6 binding complex. Arrows
designate binding complexes containing STAT1 orSTAT6. Data From Guo et al. (20).
complexes were detected upon EMSA, but
as evidenced by supershift using STAT6
antibodies, only a minority ofthe protein
binding to the IL-4 GAS element was
STAT6 (20). Rather, STAT1 was the
major protein binding to the IL-4 GAS ele-
ment, as might be expected as the IL-4
GAS element contains the DNA consensus
element for STATI binding (29).
To determine if CM also activated
STAT DNA binding, we performed the
EMSA on the whole cell extract ofHAEC
treated with conditioned media. This
resulted in high levels ofSTATI activation
(Figure 7). Interestingly, this complex was
more prominent than the complex detected
in HAEC stimulated directly with IFN-,y
and IL-4. Moreover, CM resulted in a
prominent binding complex ofthree bands
using IL-4 GAS as the probe. Supershift
analyses demonstrated that the predomi-
nant protein binding to the IL-4 GAS was
STATI, with only a very low level of
STAT6 detectable in the binding complex.
The presence ofthree distinct bands using
the IL-4 GAS probe was best appreciated
following supershift ofthe STATI (Figure
7, lane 11). The activation ofthree distinct
protein-DNA complexes by CM suggests
homo- and heterodimeric complexing of
STAT proteins (33-35). Supershift analy-
ses indicated that the fastest moving com-
plex contained STAT1 homodimers and
the slowest moving complex homodimers
ofSTAT6, with the intermediate complex
representing a heterodimeric complex of
STATs. In addition, IL-4 alone induced
only the faint upper band complex (20).
These results supported the finding that
continued signaling through cell surface
receptors was responsible for ongoing
iNOS gene expression over time in HAEC.
Summary
These results demonstrate the complex
nature of the regulation of iNOS gene
expression in airway epithelial cells. Our
findings indicate that IFN-yis sufficient to
induce iNOS in human airway epithelium,
with potentiation ofiNOS expression by
IL-4 through prolongation ofthe half-life
ofthe mRNA. Importantly, this combina-
tion ofcytokines is biologically relevant to
expression ofiNOS in airway epithelium
in vivo, as IL-4 and IFN-ywere detected in
fluid lining the lung epithelium sampled
from healthy volunteers. On the basis of
our findings, we propose a mechanism for
iNOS induction and maintenance in
human airway epithelium in which IFN-y
and IL-4 in the epithelial lining fluid lead
to epithelial production ofsoluble media-
tor(s) that stimulate the airway epithelium
in an autocrine and paracrine fashion to
express iNOS.
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